Relisys is a forward-thinking company that specializes in creating advanced cardiovascular medical devices aimed at providing life-saving treatments for heart-related conditions. Their product line includes coronary stent systems, PTCA balloon catheters, angiographic diagnostic catheters, guiding catheters, coronary vascular accessories, and transcatheter heart valves. Founded in 1997, the company has been at the forefront of innovation in the Health Care and Manufacturing industries.
In September 2021, Relisys secured a INR100.00M investment in a Private Equity Round led by Siguler Guff. This funding will likely enable the company to further enhance its product line, expand its market reach, and continue developing cutting-edge medical solutions for severe heart diseases.
